These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1405703)
21. p75c-myb expression in leukemia-lymphoma cells correlated with proliferation and differentiation. Ohnishi H; Kamano H; Tanaka T; Okabe A; Irino S Leuk Res; 1990; 14(5):423-32. PubMed ID: 2189045 [TBL] [Abstract][Full Text] [Related]
22. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications. Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235 [TBL] [Abstract][Full Text] [Related]
23. MYC protein expression does not correlate with MYC abnormalities detected by FISH but predicts an unfavorable prognosis in de novo acute myeloid leukemia. Chen P; Redd L; Schmidt Y; Koduru P; Fuda F; Montgomery-Goecker C; Kumar K; Xu-Monette Z; Young K; Collins R; Chen W Leuk Res; 2021 Jul; 106():106584. PubMed ID: 33933715 [TBL] [Abstract][Full Text] [Related]
24. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Pelicci PG; Lanfrancone L; Brathwaite MD; Wolman SR; Dalla-Favera R Science; 1984 Jun; 224(4653):1117-21. PubMed ID: 6585957 [TBL] [Abstract][Full Text] [Related]
26. Protooncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: A Leukemia Intergroup pilot study. Preisler HD; Raza A; Larson R; LeBeau M; Browman G; Goldberg J; Grunwald H; Volger R; Verkh L; Singh P Blood; 1989 Jan; 73(1):255-62. PubMed ID: 2910363 [TBL] [Abstract][Full Text] [Related]
27. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia. Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862 [TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of "short-term" effects of chemotherapy on MYC and histone H3 mRNA levels in acute leukemia patients. Venturelli D; Lange B; Narni F; Selleri L; Mariano MT; Torelli U; Gewirtz AM; Calabretta B Proc Natl Acad Sci U S A; 1988 May; 85(10):3590-4. PubMed ID: 3285345 [TBL] [Abstract][Full Text] [Related]
29. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Anfossi G; Gewirtz AM; Calabretta B Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445 [TBL] [Abstract][Full Text] [Related]
30. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals. Shipp MA; Reinherz EL J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides. Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957 [TBL] [Abstract][Full Text] [Related]
32. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML. Cuenco GM; Nucifora G; Ren R Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1760-5. PubMed ID: 10677531 [TBL] [Abstract][Full Text] [Related]
33. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Calabretta B; Sims RB; Valtieri M; Caracciolo D; Szczylik C; Venturelli D; Ratajczak M; Beran M; Gewirtz AM Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2351-5. PubMed ID: 2006173 [TBL] [Abstract][Full Text] [Related]
34. [Altered expression of protooncogenes during clinical course in an AML case transformed from MDS]. Fujikawa T; Horiguchi J; Iizuka K; Nemoto T; Iwase S; Yamamura S; Inaba S; Yamazaki Y; Sano S; Yamada H Rinsho Ketsueki; 1991 Sep; 32(9):986-90. PubMed ID: 1942545 [TBL] [Abstract][Full Text] [Related]
35. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children]. Pituch-Noworolska A Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422 [TBL] [Abstract][Full Text] [Related]
36. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032 [TBL] [Abstract][Full Text] [Related]
37. The relationship of the in vivo cell cycle characteristics and treatment outcome in acute myelogenous leukemia to the expression of the FMS and MYC proto-oncogenes. Preisler HD; Raza A; Larson R; Goldberg J; Tricot G; Browman G; Bennett J Leuk Lymphoma; 1994 Jul; 14(3-4):273-8. PubMed ID: 7950916 [TBL] [Abstract][Full Text] [Related]
38. Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission. Preisler HD; Kinniburgh AJ; Wei-Dong G; Khan S Cancer Res; 1987 Feb; 47(3):874-80. PubMed ID: 2433029 [TBL] [Abstract][Full Text] [Related]
39. c-myc and c-myb oncoproteins during induced maturation of human myeloid and erythroid leukaemic lines. Bains MA; Pedrazzoli P; Hoy TG; Jacobs A Haematol Blood Transfus; 1989; 32():343-6. PubMed ID: 2696685 [No Abstract] [Full Text] [Related]
40. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes. Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]